GTS Securities’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,700
Closed -$15.3M 2459
2024
Q3
$15.3M Buy
37,700
+21,700
+136% +$7.94M 0.03% 343
2024
Q2
$5.14M Sell
16,000
-14,200
-47% -$4.61M 0.01% 846
2024
Q1
$10.1M Sell
30,200
-3,900
-11% -$1.19M 0.02% 506
2023
Q4
$9.23M Sell
34,100
-18,600
-35% -$4.6M 0.02% 652
2023
Q3
$13M Buy
+52,700
New +$14.4M 0.02% 489

Other funds holding HCA

GTS Securities's HCA Position: Q1 2026 in Review

GTS Securities reduced its HCA Healthcare (HCA) stake by 30% in Q1 2026, selling an estimated $223K and leaving 1,044 shares worth $494K. The position accounts for 0.02% of the portfolio, ranked #753.

GTS Securities first reported a position in HCA in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.1M in Q3 2023. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • GTS Securities held 1,044 shares of HCA Healthcare worth $494K as of Q1 2026.
  • GTS Securities sold 442 HCA Healthcare shares in Q1 2026, an estimated $223K.
  • HCA Healthcare made up 0.02% of GTS Securities's portfolio in Q1 2026, its #753 holding.
  • GTS Securities first reported a position in HCA Healthcare in Q3 2023 and has held it in 10 quarters since.
  • GTS Securities's HCA Healthcare position peaked at $2.1M in Q3 2023.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.